SEC 13F Intelligence

Aufman Associates Inc / APLSUSD

Aufman Associates Inc’s Apellis Pharmaceuticals Inc Position

Does Aufman Associates Inc own Apellis Pharmaceuticals Inc (APLSUSD)? Not currently — the last reported position was 46.8K shares worth $2M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2021
Shares
46.8K
% of Portfolio
+1.63%
Quarters Held
9
position exited

Position History APLSUSD

Reported value by quarter
Q4 ’19: $2MQ4 ’19Q1 ’20: $1MQ2 ’20: $2MQ2 ’20Q3 ’20: $2MQ4 ’20: $3MQ4 ’20Q1 ’21: $2MQ2 ’21: $3MQ2 ’21Q3 ’21: $2MQ4 ’21: $2MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202146.8K$2M+1.63%
Q3 202153.6K$2M+1.45%
Q2 202153.6K$3M+2.61%
Q1 202153.6K$2M+1.92%
Q4 202053.6K$3M+2.75%
Q3 202053.6K$2M+1.74%
Q2 202053.6K$2M+1.99%
Q1 202053.6K$1M+1.98%
Q4 201953.6K$2M+1.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aufman Associates Inc’s full portfolio or all institutional holders of APLSUSD.